KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Sarepta Therapeutics (SRPT) Current Assets: 2011-2025

Historic Current Assets for Sarepta Therapeutics (SRPT) over the last 14 years, with Sep 2025 value amounting to $2.7 billion.

  • Sarepta Therapeutics' Current Assets rose 1.38% to $2.7 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 billion, marking a year-over-year increase of 1.38%. This contributed to the annual value of $3.1 billion for FY2024, which is 19.16% up from last year.
  • Sarepta Therapeutics' Current Assets amounted to $2.7 billion in Q3 2025, which was up 2.46% from $2.7 billion recorded in Q2 2025.
  • Sarepta Therapeutics' 5-year Current Assets high stood at $3.1 billion for Q4 2024, and its period low was $2.2 billion during Q3 2021.
  • Its 3-year average for Current Assets is $2.6 billion, with a median of $2.6 billion in 2023.
  • In the last 5 years, Sarepta Therapeutics' Current Assets declined by 10.83% in 2021 and then rose by 20.16% in 2022.
  • Over the past 5 years, Sarepta Therapeutics' Current Assets (Quarterly) stood at $2.6 billion in 2021, then decreased by 1.78% to $2.6 billion in 2022, then rose by 0.84% to $2.6 billion in 2023, then grew by 19.16% to $3.1 billion in 2024, then increased by 1.38% to $2.7 billion in 2025.
  • Its Current Assets was $2.7 billion in Q3 2025, compared to $2.7 billion in Q2 2025 and $2.4 billion in Q1 2025.